ClassID:

94576

C07D249/06 - page 2 - CPC Classification

Classification description:

Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings 1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms

Recent Application in this class:
#301
20130315824
2013-11-28

Radioiodination method

#302
20130310569
2013-11-21

TRIAZOLIDE BASED IONIC LIQUIDS

#303
20130310558
2013-11-21

Synthesis, structure and use of functionalized naphthalenes

#304
20130296355
2013-11-07

Glucagon receptor modulators

#305
20130274298
2013-10-17

Azole compounds used as tuberculostatic and leishmanicide agents

#306
20130267568
2013-10-10

(1,2,3-triazolyl)sulfonyl derivatives

#307
20130252964
2013-09-26

Compounds and methods for treating candidiasis and aspergillus infections

#308
20130197178
2013-08-01

Crystalline 1H-1,2,3-triazol-5-ylidenes

#309
20130184469
2013-07-18

Process for preparation of rufinamide

#310
20130137635
2013-05-30

TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF METASTATIC BONE DISEASE

#311
20130096165
2013-04-18

COMPOUNDS AND METHODS FOR MODULATING G PROTEIN-COUPLED RECEPTORS

#312
20130072449
2013-03-21

Lysophosphatidic acid receptor antagonists

#313
20130060045
2013-03-07

1, 2, 4-triazole derivatives and their anti mycobacterial activity

#314
20130046000
2013-02-21

COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT

#315
20130030008
2013-01-31

Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals

#316
20130018103
2013-01-17

Bifunctional histone deacetylase inhibitors

#317
20130012547
2013-01-10

Insecticidal compounds

#318
20120322761
2012-12-20

Heterocyclic CETP inhibitors

#319
20120316313
2012-12-13

Halogen-free flame retarding materials based on bisphenol triazole resins and polymers

#320
20120316193
2012-12-13

Proteostasis regulators

#321
20120283442
2012-11-08

Chemical compounds capable of complexing at least one metal element and a coordination complex based on these compounds

#322
20120283249
2012-11-08

Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action

#323
20120270877
2012-10-25

IRE-1α inhibitors

#324
20120252815
2012-10-04

Inhibitors of sphingosine kinase

#325
20120245138
2012-09-27

N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl) arylsulfonamides

#326
20120238539
2012-09-20

Piperazine analogs as broad-spectrum influenza antivirals

#327
20120237444
2012-09-20

Iodine radiolabelling method

#328
20120232116
2012-09-13

FXR (NR1H4) binding and activity modulating compounds

#329
20120202834
2012-08-09

Glucagon receptor modulators

#330
20120178750
2012-07-12

Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment

#331
20120172405
2012-07-05

Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4-1,2,4-triazol-3-ylthio)acetic acid and uses thereof

#332
20120165542
2012-06-28

Copper-catalysed ligation of azides and acetylenes

#333
20120157484
2012-06-21

Tryptophan hydroxylase inhibitors

#334
20120142935
2012-06-07

Copper catalyzed cycloaddition of organic azides and 1-haloalkynes

#335
20120142846
2012-06-07

4- and 5 substituted 1,2,3-triazole moieties with at least one remote polymerizable moiety and polymers thereof

#336
20120142671
2012-06-07

Benzamides and nicotinamides as Syk modulators

#337
20120135975
2012-05-31

Substituted Esters as Cannabinoid-1 Receptor Modulators

#338
20120122780
2012-05-17

Compounds, Compositions and Methods for Modulating Uric Acid Levels

#339
20120101266
2012-04-26

F-labeled azide compound, reagent for F-labeling and method for F-labeling of alkyne compound using same

#340
20120101099
2012-04-26

HISTONE DEACETYLASE INHIBITORS

#341
20120101096
2012-04-26

Compounds and methods for treating mammalian gastrointestinal microbial infections

#342
20120077856
2012-03-29

PHARMACEUTICAL PRODUCT

#343
20120035217
2012-02-09

Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors

#344
20120022118
2012-01-26

Compounds for the treatment of proliferative disorders

#345
20120004261
2012-01-05

MIF modulators

#346
20120004227
2012-01-05

Cyclohexane derivative having NPY Y5 receptor antagonism

#347
20120004211
2012-01-05

1,2,4-triazole derivatives as sigma receptor inhibitors

#348
20120004198
2012-01-05

Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators

#349
20110294819
2011-12-01

Hepatitis C virus inhibitors

#350
20110294818
2011-12-01

1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy

#351
20110282071
2011-11-17

1,2,3-triazole based metal-organic framework as photo-active materials

#352
20110274654
2011-11-10

Triazoles as inhibitors of fatty acid synthase

#353
20110269803
2011-11-03

Azole compounds used as tuberculostatic and leishmanicide agents

#354
20110245271
2011-10-06

Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists

#355
20110201656
2011-08-18

NOVEL DIPHENYL 1,2,3-TRIAZOLE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS

#356
20110201601
2011-08-18

Inhibitors of the Shiga toxins trafficking through the retrograde pathway

#357
20110190205
2011-08-04

Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide

#358
20110184177
2011-07-28

CXCR2 inhibitors

#359
20110172278
2011-07-14

Compounds and methods for modulating G protein-coupled receptors

#360
20110160208
2011-06-30

DIARYL-SUBSTITUTED FIVE-MEMBERED HETEROCYCLE DERIVATIVE

#361
20110160207
2011-06-30

Heterocyclic amide compounds useful as kinase inhibitors

#362
20110160165
2011-06-30

7-pyrazolyl tetracycline compounds and methods of use thereof

#363
20110158907
2011-06-30

DIPHENYL-HETEROARYL DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES

#364
20110152290
2011-06-23

Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals

#365
20110130562
2011-06-02

Surfactant-enabled transition metal-catalyzed chemistry

#366
20110124559
2011-05-26

Compounds as antagonists or inverse agonists at opioid receptors

#367
20110112282
2011-05-12

IDO INHIBITORS AND THERAPEUTIC USES THEREOF

#368
20110105765
2011-05-05

UV-absorbers for ophthalmic lens materials

#369
20110105764
2011-05-05

Copper-catalysed ligation of azides and acetylenes

#370
20110082295
2011-04-07

Therapeutic agent for Alzheimer's disease

#371
20110065725
2011-03-17

TRIAZOLE AMIDE DERIVATIVES FOR USE IN THERAPY

#372
20110060017
2011-03-10

NOVEL 1,2,3-TRIAZOLE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS

#373
20110053975
2011-03-03

Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies

#374
20110045101
2011-02-24

FUNGICIDAL SUBSTITUTED AZOLES

#375
20110039851
2011-02-17

CCR10 antagonists

#376
20100331302
2010-12-30

N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl)hetaryl arylsulfonamides

#377
20100317842
2010-12-16

Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry

#378
20100317647
2010-12-16

Cyclopentane derivatives

#379
20100286131
2010-11-11

VIRAL POLYMERASE INHIBITORS

#380
20100280054
2010-11-04

Multicyclic amino acid derivatives and methods of their use

#381
20100279873
2010-11-04

Halogen alkoxy spirocyclic tetramic and tetronic acid derivatives

#382
20100279410
2010-11-04

COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS

#383
20100278730
2010-11-04

Non-Invasive Molecular Imaging of Cellular Histone Deacetylase Substrate Using Magnetic Resonance Spectroscopy (MRS) or Positron Emission Tomography (PET)

#384
20100267669
2010-10-21

Heterocyclic CETP inhibitors

#385
20100222398
2010-09-02

1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors

#386
20100216827
2010-08-26

ARYL GPR120 RECEPTOR AGONISTS AND USES THEREOF

#387
20100207068
2010-08-19

Process for producing purified synthesis gas from synthesis gas comprising trace amounts of sulphur contaminants with a metal-organic framework

#388
20100204472
2010-08-12

Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation

#389
20100184815
2010-07-22

AGONISTS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-ALPHA

#390
20100173899
2010-07-08

Dipeptide analogs as coagulation factor inhibitors

#391
20100160343
2010-06-24

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

#392
20100160341
2010-06-24

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

#393
20100160323
2010-06-24

NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE

#394
20100152045
2010-06-17

Phenylalkyl substituted heteroaryl derivatives

#395
20100144778
2010-06-10

Niacin receptor agonists, compositions containing such compounds and methods of treatment

#396
20100144747
2010-06-10

N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihydro-2H-quinazolin-3-yl)methanesulfonamide

#397
20100144734
2010-06-10

1, 2, 3-triazole derivatives as new cannabinoid-1 receptor antagonists

#398
20100137338
2010-06-03

Inhibitors of Akt activity

#399
20100120876
2010-05-13

Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide

#400
20100120714
2010-05-13

Substituted benzene fungicides

#401
20100105904
2010-04-29

UREA TYPE CINNAMIDE DERIVATIVE

#402
20100087468
2010-04-08

MODULATORS OF PPAR AND METHODS OF THEIR PREPARATION

#403
20100081826
2010-04-01

Process for preparing five-membered heterocyclyl tetracycline compounds and methods of use thereof

#404
20100048699
2010-02-25

CHEMICAL COMPOUNDS

#405
20100004265
2010-01-07

1,2,3-triazole derivatives as sigma receptor inhibitors

#406
20100004224
2010-01-07

1,2,4-triazole derivatives as sigma receptor inhibitors

#407
20090326240
2009-12-31

Iron-copper co-catalyzed process for carbon-carbon or carbon-heteroatom bonding

#408
20090312363
2009-12-17

Bifunctional histone deacetylase inhibitors

#409
20090270367
2009-10-29

Substituted hydroxyethylamine aspartyl protease inhibitors

#410
20090239798
2009-09-24

Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide

#411
20090181943
2009-07-16

Inhibitors of histone deacetylase

#412
20090181402
2009-07-16

COMPOSITIONS AND METHODS FOR COUPLING A PLURALITY OF COMPOUNDS TO A SCAFFOLD

#413
20090171008
2009-07-02

Functionalized (meth)acrylic monomers and polymers for acetylenic alcohols

#414
20090170874
2009-07-02

Triazole-substituted arylamides as P2Xand P2Xantagonists

#415
20090137611
2009-05-28

Fungicide N-cyclopropyl-sulfonylamide derivatives

#416
20090123372
2009-05-14

Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry

#417
20090105273
2009-04-23

Diacylglycerol acyltransferase inhibitors

#418
20090105253
2009-04-23

Triazole derivative and use thereof

#419
20090093524
2009-04-09

Compounds and methods for modulating FXR

#420
20090069569
2009-03-12

CYCLOADDITION OF AZIDES AND ALKYNES

#421
20090069288
2009-03-12

Novel therapeutic compounds

#422
20090062355
2009-03-05

Pharmaceutical Product

#423
20090054501
2009-02-26

AZOLE COMPOUNDS USED AS TUBERCULOSTATIC AND LEISHMANICIDE AGENTS

#424
20090043105
2009-02-12

Ophthalmic lens materials containing chromophores that absorb both UV and short wavelength visible light

#425
20090043007
2009-02-12

Ophthalmic lens materials containing chromophores that absorb both UV and short wavelength visible light

#426
20090023916
2009-01-22

Tetrazine-based bio-orthogonal coupling reagents and methods

#427
20090023730
2009-01-22

Substituted aryl acylthioureas and related compounds; inhibitors of viral replication

#428
20090023669
2009-01-22

Antibacterial agents

#429
20090005410
2009-01-01

N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides

#430
20080275127
2008-11-06

Arylsulfonamido-substituted hydroxamic acid derivatives

#431
20080266519
2008-10-30

UV-absorbers for ophthalmic lens materials

#432
20080262046
2008-10-23

Amidopropoxyphenyl Orexin Receptor Antagonists

#433
20080234278
2008-09-25

Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions

#434
20080214831
2008-09-04

Copper-catalysed ligation of azides and acetylenes

#435
20080214448
2008-09-04

Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide

#436
20080200519
2008-08-21

TETRAHYDRONAPHTHALENYLAMIDES, A PROCESS FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY AGENTS

#437
20080176916
2008-07-24

α-Amino-N-hydroxy-acetamide derivatives

#438
20080171741
2008-07-17

Heterocyclic amide compounds useful as kinase inhibitors

#439
20080153836
2008-06-26

Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands

#440
20080139599
2008-06-12

Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof

#441
20080132459
2008-06-05

Inhibitors of histone deacetylase

#442
20080108630
2008-05-08

SUBSTITUTED TRIAZOLES AS MODULATORS OF PPAR AND METHODS OF THEIR PREPARATION

#443
20080096892
2008-04-24

C-kit modulators and methods of use

#444
20080090854
2008-04-17

CXCR2 inhibitors

#445
20080027060
2008-01-31

DIPEPTIDE NITRILES

#446
20070293423
2007-12-20

Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide

#447
20070281952
2007-12-06

Arylsulfonylnaphthalene derivatives as 5HTantagonists

#448
20070259879
2007-11-08

Piperazine and piperidine biaryl derivatives

#449
20070244119
2007-10-18

1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease

#450
20070238699
2007-10-11

Compounds for the treatment of proliferative disorders

#451
20070213316
2007-09-13

N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives

#452
20070191389
2007-08-16

Biaryl derivatives

#453
20070191370
2007-08-16

Multicyclic amino acid derivatives and methods of their use

#454
20070185178
2007-08-09

Triazole compounds and their use as metabotropic glutamate receptor antagonists

#455
20070173507
2007-07-26

Diaryl-substituted five-membered heterocycle derivative

#456
20070167426
2007-07-19

Compounds for the treatment of inflammatory disorders and microbial diseases

#457
20070135631
2007-06-14

Heterocyclic CETP inhibitors

#458
20070129369
2007-06-07

Heteroaryl substituted cyclohexyl-1,4-diamine compounds

#459
20070119341
2007-05-31

Azo compound, aqueous dye solutions containing the same, inks and use thereof

#460
20070105842
2007-05-10

P2Xreceptor antagonists and methods of use

#461
20070099921
2007-05-03

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

#462
20070088058
2007-04-19

Aralkyl amines as cannabinoid receptor modulators

#463
20070043220
2007-02-22

Pyrazole derivative as PPAR modulator

#464
20070032492
2007-02-08

Cytokine inhibitors

#465
20070021442
2007-01-25

HIV reverse transcriptase inhibitors

#466
20070020620
2007-01-25

Compositions and methods for coupling a plurality of compounds to a scaffold

#467
20060293364
2006-12-28

Niacin receptor agonists, compositions containing such compounds and methods of treatment

#468
20060270719
2006-11-30

α-amino-N-hydroxy-acetamide derivatives

#469
20060241157
2006-10-26

Heterocyclic ppar modulators

#470
20060235220
2006-10-19

Dipeptide nitriles

#471
20060223866
2006-10-05

Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity

#472
20060166990
2006-07-27

Aminobenzophenone compounds

#473
20060160794
2006-07-20

Tachykinin receptor antagonists

#474
20060128766
2006-06-15

Triazole substituted aminobenzophenone compounds

#475
20060084680
2006-04-20

Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation

#476
20060084634
2006-04-20

Five-membered heterocyclyl tetracycline compounds and methods of use thereof

#477
20060074115
2006-04-06

Hexafluoroisopropanol substituted ether derivatives

#478
20060058301
2006-03-16

Modulators of PPAR and methods of their preparation

#479
20060025547
2006-02-02

Styrene polymers and phenol-triazole type complexes, catalysts, and processes for polymerizing

#480
20060025416
2006-02-02

Substituted aryl acylthioureas and related compounds; inhibitors of viral replication

#481
20060019997
2006-01-26

Triazole compounds and their use as metabotropic glutamate receptor antagonists

#482
20060014836
2006-01-19

Substituted aryl thioureas and related compounds; inhibitors of viral replication

#483
20060014809
2006-01-19

Substituted triazoles as modulators of PPAR and methods of their preparation

#484
20060008670
2006-01-12

Organic light emitting materials and devices

#485
20050272789
2005-12-08

Triazole-derived kinase inhibitors and uses thereof

#486
20050261293
2005-11-24

Compounds which inhibit leukocyte adhesion mediated by VLA-4

#487
20050245526
2005-11-03

Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions

#488
20050239836
2005-10-27

Substituted hydroxyethylamine aspartyl protease inhibitors

#489
20050239786
2005-10-27

Triazole derivatives as tachykinin receptor antagonists

#490
20050239776
2005-10-27

Tachykinin receptor antagonists

#491
20050222427
2005-10-06

Copper-catalysed ligation of azides and acetylenes

#492
20050209223
2005-09-22

Antibacterial compounds: process for their preparation and pharmaceutical compositions containing them

#493
20050203093
2005-09-15

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

#494
20050187266
2005-08-25

Alpha substituted carboxylic acids

#495
20050153972
2005-07-14

Triazole compounds

#496
20050143578
2005-06-30

Compounds and methods

#497
20050119312
2005-06-02

Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method

#498
20050113347
2005-05-26

Antibacterial compounds: process for their preparation and pharmaceutical compositions containing them

#499
20050080121
2005-04-14

Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis

#500
20050065066
2005-03-24

Stabilised insulin compositions

#501
20050020584
2005-01-27

Benzamide derivatives as antagonists of orexin receptors

#502
20050014938
2005-01-20

Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinase

#503
20050004116
2005-01-06

Triazole inhibitors of type 2 methionine aminopeptidase

#504
18914691
2025-03-25

Aryl-1,2,3-triazole compounds, pharmaceutical composition thereof and method for treatment of breast cancer

#505
17032529
2022-05-24

Calpain modulators and therapeutic uses thereof

#506
16765143
2022-07-05

Small molecule modulators of IL-17

#507
14951210
2018-05-15

Synthesis and polymerization of vinyl triazolium ionic liquids

#508
14465257
2016-01-19

Synthesis of 4-(pentafluorosulfanyl)benzenediazonium tetrafluoroborate and analogs and their application for the preparation of SF-aromatics